1. Repositório Institucional - INCA
  2. Assistência
  3. Informe SUS - ONCO
  4. Informe SUS - ONCO 2021
Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/3817
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.contributor.authorSistema Único de Saúde (Brasil)-
dc.contributor.authorBrasil. Ministério da Saúde-
dc.date.accessioned2021-08-31T17:35:10Z-
dc.date.available2021-08-31T17:35:10Z-
dc.date.issued2021-07-
dc.identifier.urihttp://sr-vmlxaph03:8080/jspui/handle/123456789/3817-
dc.description3 p.: il. p&b.-
dc.language.isoportpt_BR
dc.publisherINCApt_BR
dc.relation.ispartofseriesAno V, n. 50.-
dc.subjectLeucemia Linfoblástica Agudapt_BR
dc.subjectMesilato de Imatinibpt_BR
dc.subjectNeoplasiaspt_BR
dc.subjectImatinib Mesylate-
dc.subjectLeucemia-Linfoma Linfoblástico de Células Precursoras-
dc.subjectPrecursor Cell Lymphoblastic Leukemia-Lymphoma-
dc.subjectNeoplasms-
dc.titlePortaria conjunta nº 11, de 2 de julho de 2021pt_BR
dc.TypeRevistas/Boletinspt_BR
Appears in Collections:Informe SUS - ONCO 2021

Files in This Item:
File Description SizeFormat 
informe-sus-onco-julho-2021_0.pdf571.74 kBAdobe PDFView/Open
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.